Ob/Gyn Department Meeting: Fetal Fibronectin and Prediction of Preterm Delivery

Miami, FL US
May 12, 2017

Preterm birth is an important cause of perinatal morbidity and mortality. Various biomarkers in cervicovaginal secretions related to preterm birth have been investigated, of which fetal fibronectin (fFN) shows the greatest potential because of its high negative predictive value. Accurate prediction of the risk of spontaneous preterm birth is crucial for the clinical management of patients with preterm labor. The identification of women truly in preterm labor allows appropriate application of interventions that can improve neonatal outcome.

Target Audience

Obstetricians and Gynecologists

 

  • Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients.
  • Implement strategies utilizing fFN to more accurately identify patients in preterm labor.
  • Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women.
  • Apply management strategies and interventions for preterm birth to improve clinical outcomes.

Learning Objectives


 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance
Course opens: 
01/08/2017
Course expires: 
05/26/2017
Event starts: 
05/12/2017 - 8:00am
Event ends: 
05/12/2017 - 9:00am
Rating: 
0
Baptist Hospital
8900 N. Kendall Dr
Miami, FL 33176
United States

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance

Accreditation Period

Course opens: 
01/08/2017
Course expires: 
05/26/2017
Please login or register to take this course.